Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
Biotech
LB Pharmaceuticals eyes $228M in IPO cash
The CNS-focused company is looking to pull off the first biotech IPO since February and collect $228.5 million in much-needed funding.
Zoey Becker
Sep 8, 2025 3:16pm
Heartflow pumps up IPO plans to $300M
Aug 6, 2025 11:20am
Coronary AI diagnostic developer Heartflow files $100M IPO
Jul 18, 2025 11:43am
Personalized spine surgery developer Carlsmed plots $100M+ IPO
Jul 16, 2025 11:44am
Caris Life Sciences ups IPO to raise $494M
Jun 18, 2025 11:00am
Caris Life Sciences to go public in $400M Nasdaq IPO
Jun 9, 2025 10:30am
